Latest news
Results: Eisai Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.stsimplywall.st · Wed, 05 Aug 2026 21:49:38 GMTEisai Launches Leqembi in India for Early Alzheimer’s Disease - NAVLIN DAILYNAVLIN DAILY · Tue, 04 Aug 2026 08:03:14 GMTEisai Earnings Call Highlights LEQEMBI-Driven Surge - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 00:02:00 GMTAlzheimer’s rival Eli Lilly, Eisai lock horns in India - ET PharmaET Pharma · Mon, 03 Aug 2026 14:21:35 GMTEisai and CORE Biomedicine agree on global licence for oncology pipeline - Pharmaceutical TechnologyPharmaceutical Technology · Wed, 29 Jul 2026 07:54:40 GMTCORE Biomedicine Signs Exclusive Licensing Agreement with Eisai for Precision Oncology Programs - PR NewswirePR Newswire · Tue, 28 Jul 2026 12:21:00 GMTPfizer and Eisai Commence Co-promotion of "NURTEC(R)" for the Acute Treatment and Prophylaxis (Preventive Treatment) of Migraine - acnnewswire.comacnnewswire.com · Mon, 27 Jul 2026 14:50:00 GMT